STAT reporters discuss why a looming patent cliff could lead to more pharmaceutical deal-making and a new obesity startup.

Under the terms of the deal, Alchemab and Lilly will work together on up to five new antibodies, according to a Jan. 9 ...

First, meet Ebony, a lovable 1-year-old pit bull with the kindest heart. Ebony is a gentle soul who adores attention and is sweet to everyone she meets. Whether it's a new friend or a familiar face, ...

Cats come in a wide variety of colors and coat patterns. Some breeds are more immediately recognizable than others. Torbie ...

Freshwater environments cover about 1% of Earth's surface while accounting for more than 10% of known species. Like many ...

In studies by Massachusetts General Hospital, the AbbVie-Calico collaborative drug and Denali Therapeutics' own drug failed to meet endpoints for treating amyotrophic lateral sclerosis, more widely ...

Denali’s medicine and a similar one from Calico Life Sciences and AbbVie were not much different than a placebo, bringing the ...

A fierce bird attacked a calico cat lurking under its tree territory. Footage shows the oriental magpie robin swooping down ...

A clinical trial evaluating the drug fosigotifator in patients with amyotrophic lateral sclerosis has failed to meet its primary endpoint, according to topline results from the Healey ALS platform ...

Google’s ( GOOGL) anti-aging company Calico released disappointing trial results of its first ever drug.

The company said Monday that fosigotifator failed to outperform placebo in slowing the neurodegenerative disease, but is ...